Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Column Packing and Unpacking – V 2.0

Posted on By


Biosimilars: SOP for Column Packing and Unpacking – V 2.0


Standard Operating Procedure for Column Packing and Unpacking in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/165/2025
Supersedes SOP/BS/165/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the procedure for packing and unpacking chromatography columns used in biosimilar purification under GMP conditions, ensuring column efficiency, reproducibility, and resin integrity.

2. Scope

This SOP applies to all preparative chromatography columns (glass or stainless steel) used in downstream processing at lab or manufacturing scale for biosimilar monoclonal antibody or protein purification.

3. Responsibilities

  • Production: Perform packing/unpacking as per validated protocols and record all observations.
  • QA: Review packing logs and approve column integrity before use.
  • Engineering: Ensure equipment readiness and flow control system calibration.

4. Accountability

The Head of Downstream Manufacturing is accountable for maintaining column performance and compliance with GMP during all packing and unpacking activities.

5. Procedure

5.1 Column Packing

  1. Preparation:
    • Inspect and clean column housing, frits, adaptors, and seals.
    • Ensure the packing station and packing buffer are ready.
  2. Slurry Preparation:
    • Mix resin with packing buffer (1:2 to 1:3 ratio).
    • Degas and allow settling for uniform distribution.
  3. Packing Process:
    • Close bottom outlet, pour slurry into the column tube.
    • Attach the top adapter gently and allow air to escape.
    • Initiate flow at recommended flow rate (e.g., 300 cm/hr) and pack under gravity or pump pressure.
  4. Compression and Stabilization:
    • Move adapter slowly to the settled bed and lock in place.
    • Flow equilibration buffer at operating flow rate and monitor pressure.
    • Record asymmetry and plate height to assess packing efficiency.

5.2 Column Testing

  1. Run a test with 1% acetone or NaCl solution to verify asymmetry and theoretical plates.
  2. Acceptance Criteria:
    • Asymmetry factor: 0.8–1.8
    • Number of theoretical plates: >2000 per meter

5.3 Column Unpacking

  1. Disconnect column from skid and drain buffer from resin bed.
  2. Remove top adapter and slowly release slurry into disposal vessel or clean container for reuse.
  3. Rinse column tube and all parts with WFI and store as per cleaning SOP.
  4. Log unpacking date and any damage to column or frits in Annexure-2.

5.4 Post-Packing Documentation

  1. Record:
    • Resin lot number
    • Column ID and dimensions
    • Packing buffer details
    • Bed height, asymmetry, theoretical plates
  2. Attach chromatogram and packing test results in Annexure-3.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • WFI: Water for Injection
  • SEC: Size Exclusion Chromatography
  • CV: Column Volume

7. Documents

  1. Column Packing Record – Annexure-1
  2. Column Unpacking Record – Annexure-2
  3. Packing Evaluation Report – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – GMP Guidelines for Biologics
  • OEM Manuals – Cytiva, Pall, and Millipore Chromatography Columns

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Column Packing Record

Column ID Resin Lot No. Bed Height Packing Buffer Flow Rate Date Operator
COL-102 SP-9802 20 cm 20 mM Phosphate 300 cm/hr 04/05/2025 Ajay Verma

Annexure-2: Column Unpacking Record

Column ID Date Resin Recovered? Condition Remarks Operator
COL-102 04/05/2025 Yes Good No cracks Sunita Reddy

Annexure-3: Packing Evaluation Report

Column ID Asymmetry Theoretical Plates Pass/Fail Analyst Date
COL-102 1.1 2850/m Pass Vinay Pawar 04/05/2025

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added detailed resin testing and asymmetry range Process harmonization and QA audit recommendation
See also  Biosimilars: SOP for Addition of Antifoam Agents in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Qualification of Transfer Lines and Hoses – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Preventive Maintenance of Injectable Filling Machines – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version